These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 21577272)

  • 21. Do we need pharmacological therapy for atrial fibrillation in the ablation era?
    Lévy S
    J Interv Card Electrophysiol; 2006 Dec; 17(3):189-94. PubMed ID: 17340189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic Maintenance of Sinus Rhythm in Patients with Atrial Fibrillation Using Antiarrhythmic Drugs: Update 2010.
    Morrow JP; Reiffel JA
    Card Electrophysiol Clin; 2010 Sep; 2(3):409-418. PubMed ID: 28770799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of atrial fibrillation.
    Hersi A; Wyse DG
    Curr Probl Cardiol; 2005 Apr; 30(4):175-233. PubMed ID: 15778690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Newer developments in the management of atrial fibrillation.
    Nattel S
    Am Heart J; 1995 Nov; 130(5):1094-106. PubMed ID: 7484742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atrial Fibrillation: The New Epidemic of the Ageing World.
    Aronow WS; Banach M
    J Atr Fibrillation; 2009; 1(6):154. PubMed ID: 28496617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation: JACC State-of-the-Art Review.
    Camm AJ; Naccarelli GV; Mittal S; Crijns HJGM; Hohnloser SH; Ma CS; Natale A; Turakhia MP; Kirchhof P
    J Am Coll Cardiol; 2022 May; 79(19):1932-1948. PubMed ID: 35550691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry).
    Lip GY; Laroche C; Ioachim PM; Rasmussen LH; Vitali-Serdoz L; Petrescu L; Darabantiu D; Crijns HJ; Kirchhof P; Vardas P; Tavazzi L; Maggioni AP; Boriani G
    Eur Heart J; 2014 Dec; 35(47):3365-76. PubMed ID: 25176940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rhythm versus rate control strategies regarding anticoagulant use in elderly non-valvular atrial fibrillation patients: Subanalysis of the ANAFIE (All Nippon AF In the Elderly) Registry.
    Yuzawa H; Inoue H; Yamashita T; Akao M; Atarashi H; Koretsune Y; Okumura K; Shimizu W; Tsutsui H; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Kaburagi J; Takita A; Ikeda T
    J Cardiol; 2020 Jul; 76(1):87-93. PubMed ID: 32081607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
    Valembois L; Audureau E; Takeda A; Jarzebowski W; Belmin J; Lafuente-Lafuente C
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD005049. PubMed ID: 31483500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risks and benefits of rate control versus maintenance of sinus rhythm.
    Saxonhouse SJ; Curtis AB
    Am J Cardiol; 2003 Mar; 91(6A):27D-32D. PubMed ID: 12670639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of rhythm control in persistent or permanent atrial fibrillation with overdrive atrial pacing and antiarrhythmic drugs after linear right atrial catheter ablation.
    Filipecki A; Saksena S; Lin WH
    Am J Cardiol; 2003 Nov; 92(9):1037-44. PubMed ID: 14583353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrial fibrillation and stroke: the evolving role of rhythm control.
    Patel TK; Passman RS
    Curr Treat Options Cardiovasc Med; 2013 Jun; 15(3):299-312. PubMed ID: 23397289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antiarrhythmic drugs in paroxysmal atrial fibrillation. When and how?].
    Lévy S; Ricard P; Yapo F; Mansouri C
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():19-24. PubMed ID: 8734159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progression of paroxysmal atrial fibrillation to persistent atrial fibrillation in patients with bradyarrhythmias.
    Saksena S; Hettrick DA; Koehler JL; Grammatico A; Padeletti L
    Am Heart J; 2007 Nov; 154(5):884-92. PubMed ID: 17967594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of the older person with atrial fibrillation.
    Aronow WS
    J Gerontol A Biol Sci Med Sci; 2002 Jun; 57(6):M352-63. PubMed ID: 12023264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term rhythm control of drug-refractory atrial fibrillation with "hybrid therapy" incorporating dual-site right atrial pacing, antiarrhythmic drugs, and right atrial ablation.
    Madan N; Saksena S
    Am J Cardiol; 2004 Mar; 93(5):569-75. PubMed ID: 14996581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Epidemiology and therapy of atrial fibrillation].
    Capucci A; Aschieri D; Villani GQ
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():5S-10S. PubMed ID: 9004821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New pharmacological targets and treatments for atrial fibrillation.
    Carlsson L; Duker G; Jacobson I
    Trends Pharmacol Sci; 2010 Aug; 31(8):364-71. PubMed ID: 20605645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acupuncture for paroxysmal and persistent atrial fibrillation: An effective non-pharmacological tool?
    Lombardi F; Belletti S; Battezzati PM; Lomuscio A
    World J Cardiol; 2012 Mar; 4(3):60-5. PubMed ID: 22451853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiarrhythmic drugs for atrial fibrillation: lessons from the past and opportunities for the future.
    Heijman J; Hohnloser SH; Camm AJ
    Europace; 2021 Apr; 23(23 Suppl 2):ii14-ii22. PubMed ID: 33837753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.